Below are the earnings highlights for Vertex Pharmaceuticals Inc. (VRTX):
-Net Income: -$130.7 Mln in Q2 vs. -$141.7 Mln in the same period last year.
-EPS: -$0.54 in Q2 vs. -$0.61 in the same period last year.
-Revenue: $166.08 Mln in Q2 vs. $138.42 Mln in the same period last year.
-Guidance:
Full year revenue guidance: $575 - $590 Mln
For comments and feedback contact: editorial@rttnews.com